Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

John Mendlein


  • Director at Atyr Pharma Inc (LIFE), 2019-05-10
  • Director at Fate Therapeutics Inc (FATE), 2019-05-07
  • See Remarks at Moderna Inc. (MRNA), 2018-12-07
  • Director at Editas Medicine Inc. (EDIT), 2017-06-19
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
LIFE $0.42 195,000 Director 615,382 2018-12-21 Filing
LIFE $0.41 50,000 Director 420,382 2018-12-20 Filing
LIFE $2.65 37,736 Officer, Director 367,883 2017-08-31 Filing
LIFE $3.00 124 Officer, Director 327,647 2017-04-24 Filing
LIFE $3.00 1,552 Officer, Director 327,523 2017-04-20 Filing